Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

withdrawn133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_4

The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.

NCT04931108
withdrawnphase_4

Sympathetic Nerve Activity in Renal Failure

NCT00892892
unknownphase_4

Treatment of Hypertension in Tibetan Adult Population

NCT02217852

Clinical Trials (3)

Showing 3 of 3 trials
NCT04931108Phase 4

The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.

Unknown
NCT00892892Phase 4

Sympathetic Nerve Activity in Renal Failure

Withdrawn
NCT02217852Phase 4

Treatment of Hypertension in Tibetan Adult Population

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3